<p><b>Body weight data obtained weekly over 10 weeks (A), terminal left kidney weight for sham (N = 8), Nx (N = 8), NxE (N = 6) and NxD (N = 8) (B) and heart weight for sham (N = 8), Nx (N = 9), NxE (N = 9) and NxD (N = 8) (C) normalized to body weight at 18–20 weeks post-surgery.</b> Data are presented as mean±SD. * <i>p</i><0.05 vs sham, <sup>$</sup> <i>p</i><0.05 vs Nx, <sup>#</sup> <i>p</i><0.05 vs NxE (p<0.05).</p
Purpose: The renoprotective function of the angiotensin II type 1 receptor blocker (ARB) is well-kno...
AIMS: Patients with renal failure develop cardiovascular alterations which contribute to the higher ...
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor...
<p><b>Representative coronal view microPET scans showing liver and kidney uptake obtained at 5–10 mi...
ACE inhibitors are considered first line of treatment in patients with many forms of chronic kidney ...
<p>Treatment (Rx): ACEI (Enalapril 10mg/kg) or CCB (Diltiazem 30mg/kg) started at 10 weeks post-surg...
<p>mean ± standard deviation, <sup>1</sup> weight after perfusion fixation.</p><p>a) p<0.05 vs. corr...
Micropuncture and morphologic studies were performed in six groups of male Munich-Wistar rats after ...
Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. S...
<p>Data are presented as means ± SEM. (A) Packed cell volume (PCV), (B) systolic blood pressure (SBP...
Cardiovascular complications represent the leading cause of death in chronic kidney disease (CKD) pa...
Long-term enalapril and verapamil in rats with reduced renal mass.The effect of long-term treatment ...
Background\ud \ud Radiation-induced nephropathy is still dose limiting in radionuclide therapy of ne...
Background/Aims: The search for new therapies providing cardiorenal protection in chronic kidney dis...
Background/Aims: In experimental nephropathies, inhibitors of the renin-angiotensin-system (RAS) hal...
Purpose: The renoprotective function of the angiotensin II type 1 receptor blocker (ARB) is well-kno...
AIMS: Patients with renal failure develop cardiovascular alterations which contribute to the higher ...
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor...
<p><b>Representative coronal view microPET scans showing liver and kidney uptake obtained at 5–10 mi...
ACE inhibitors are considered first line of treatment in patients with many forms of chronic kidney ...
<p>Treatment (Rx): ACEI (Enalapril 10mg/kg) or CCB (Diltiazem 30mg/kg) started at 10 weeks post-surg...
<p>mean ± standard deviation, <sup>1</sup> weight after perfusion fixation.</p><p>a) p<0.05 vs. corr...
Micropuncture and morphologic studies were performed in six groups of male Munich-Wistar rats after ...
Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. S...
<p>Data are presented as means ± SEM. (A) Packed cell volume (PCV), (B) systolic blood pressure (SBP...
Cardiovascular complications represent the leading cause of death in chronic kidney disease (CKD) pa...
Long-term enalapril and verapamil in rats with reduced renal mass.The effect of long-term treatment ...
Background\ud \ud Radiation-induced nephropathy is still dose limiting in radionuclide therapy of ne...
Background/Aims: The search for new therapies providing cardiorenal protection in chronic kidney dis...
Background/Aims: In experimental nephropathies, inhibitors of the renin-angiotensin-system (RAS) hal...
Purpose: The renoprotective function of the angiotensin II type 1 receptor blocker (ARB) is well-kno...
AIMS: Patients with renal failure develop cardiovascular alterations which contribute to the higher ...
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor...